Federated Hermes’s OptiNose OPTN Stock Holding History

Federated Hermes’s Portfolio OPTN Stock Details OPTN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-14	Closed	-$1K	–	2242
2022 Q3	$1K	Buy	+14	New	+$769	﹤0.01%	2067

Other funds holding OPTN

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

MVM Partners Boston, Massachusetts $10.8M AUM 61.97% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return

VCIM

Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return

KCM

Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Federated Hermes's OPTN Position: Q4 2022 in Review

Federated Hermes sold out of OptiNose (OPTN) in Q4 2022, closing a stake of 14 shares — an estimated $1K sold.

Federated Hermes first reported a position in OPTN in Q3 2022 and held it in 1 quarter. The position peaked at $1K in Q3 2022. 55 funds tracked by Wall St. Rank hold OPTN as of Q4 2022.

Federated Hermes reported no remaining OptiNose position as of Q4 2022 after selling out during the quarter.
Federated Hermes sold 14 OptiNose shares in Q4 2022, an estimated $1K.
Federated Hermes first reported a position in OptiNose in Q3 2022 and held it in 1 quarter.
Federated Hermes's OptiNose position peaked at $1K in Q3 2022.
55 funds tracked by Wall St. Rank held OptiNose as of Q4 2022.

Based on Federated Hermes's 13F filing for Q4 2022, filed 13 Feb 2023.